Clinical trial / 2012
An oral 100 mg nicotinamide load increased norepinephrine and decreased metanephrine and betaine in normotensives and hypertensives.
Researchers evaluated the effect of an oral 100 mg nicotinamide loading test on methylation status and catecholamine degradation in 19 normotensive and 27 hypertensive participants. At baseline, hypertensives had higher fasting levels of plasma nicotinamide, homocysteine (Hcy), and norepinephrine, but lower normetanephrine compared with normotensives. Nicotinamide loading significantly increased plasma N(1)-methylnicotinamide and norepinephrine, and significantly decreased metanephrine and betaine in both groups. In normotensives, loading significantly increased plasma Hcy and decreased normetanephrine; post-loading epinephrine was higher in hypertensives than normotensives.
- Study type
- Interventional loading study
- Who was studied
- 19 normotensives and 27 hypertensives
- What was measured
- Plasma nicotinamide, N(1)-methylnicotinamide, homocysteine, betaine, norepinephrine, epinephrine, normetanephrine, and metanephrine levels
THE PAPER
Excess nicotinamide inhibits methylation-mediated degradation of catecholamines in normotensives and hypertensives.
Sun WP, Li D, Lun YZ, Gong XJ, Sun SX, Guo M, Jing LX, Zhang LB, Xiao FC, Zhou SS. Hypertens Res, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.